Identifying Factors for Pembrolizumab Eligibility in Head and Neck Cancer
Journal of Cancer Research and Clinical Oncology（2025）
Key words
Pembrolizumab,Head and neck cancer,Immune checkpoint inhibitors,Combined positive score (CPS),Survival analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined